RCS - OptiBiotix Health - New Investor Website

OptiBiotix HealthAnnouncement

Tue 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260120:nRST5070Pa&default-theme=true

RNS Number : 5070P  OptiBiotix Health PLC  20 January 2026

OptiBiotix Health plc

("OptiBiotix" or the "Company" or the "Group")

 

New Investor Website

OptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business
developing products which reduce hunger and food cravings, enhance the gut
microbiome, and sweet fibres as healthy sugar substitutes, announces the
launch of a new interactive investor website. The new investor website brings
all OptiBiotix content including corporate, commercial and research into a
single platform to better inform and engage with prospective and existing
investors and other stakeholders. The website includes:

●     Announcements (RNS and Reach)

●     Annual and Interim reports

●     Investor presentations, podcasts and video updates

●     Research publications, product and technology overviews

●     Interviews with the CEO

●     Interviews and videos with research/ industry partners on its
technology and products

 

The website provides users with the ability to ask the management team
questions to provide context on announcements including progress or concerns
via an interactive portal which will be monitored and responded to in a timely
manner.  The overall aim is to give existing and prospective shareholders the
opportunity to engage directly with the management team and have access to
reliable information on which they can make a judgement. We would encourage
all existing shareholders and prospective investors to sign up to the website
(it should take less than one minute) and use it as your primary interface and
information source for the business.

How to sign up for the OptiBiotix investor website:

1.    Visit www.optibiotix.com (http://www.optibiotix.com)

2.    Follow the prompts on the top right-hand side of the website marked
SIGN UP

3.    Complete your account profile (name/email)

 

Stephen O'Hara, Chief Executive Officer, commented:

"The Board is keen to improve communications with our shareholders and give
them access to reliable information on which to make their investment
decisions. This new 'InvestorHub' enables us to discuss commercial progress
with partners, share development progress and launch plans for our
second-generation products like SweetBiotix, in more depth and context than is
possible through RNS announcements alone, while remaining fully compliant with
market disclosure obligations.

We encourage all stakeholders to explore the site, engage with our content,
and share their questions and feedback. Your input is invaluable as we
continue refining our communication channels and building a profitable and
valuable business."

 

Ends

 

Engage with the OptiBiotix management team directly by asking questions,
watching video summaries and seeing what other shareholders have to say.

Navigate to our Interactive Investor website here:
https://optibiotix.com/link/P2zk3P
(https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Foptibiotix.com%2Flink%2FP2zk3P&data=05%7C02%7Cspohara%40optibiotix.com%7C91251d27127c43db20c508de57448a9a%7Cfd9d39470fcc410da8d30ce1bec67dce%7C1%7C0%7C639044149066685031%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=Bhv5yIDK4SI1agLAO8MD%2B7ykpIzY4KaVU7J%2FyuyRyks%3D&reserved=0)

Subscribe to the new website to get regular updates here:
 https://optibiotix.com/auth/signup
(https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Foptibiotix.com%2Fauth%2Fsignup&data=05%7C02%7Cspohara%40optibiotix.com%7C91251d27127c43db20c508de57448a9a%7Cfd9d39470fcc410da8d30ce1bec67dce%7C1%7C0%7C639044149066800254%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=bMsfO71mP5serbXOxQMmWA7o1XH%2FFaubVvkQiwIrc3c%3D&reserved=0)

For further enquiries, please visit www.optibiotix.com
(http://www.optibiotix.com) or contact:

 OptiBiotix Health PLC                                                        https://optibiotix.com/announcements

                                                                            (https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Foptibiotix.com%2Fannouncements&data=05%7C02%7Cspohara%40optibiotix.com%7C91251d27127c43db20c508de57448a9a%7Cfd9d39470fcc410da8d30ce1bec67dce%7C1%7C0%7C639044149066779293%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=gyC26FE1sDI5OZ7qtYftYvTLp4VOjxA4tznUs4%2FZKBc%3D&rese
 Neil Davidson, Chairman                                                      rved=0)

 Stephen O'Hara, Chief Executive

 We encourage all investors to share questions on this announcement via our
 investor website.

 

About OptiBiotix - www.optibiotix.com (http://www.optibiotix.com/)

OptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), OptiBiotix Health has
developed a range of technologies and commercialised products which modulate
the human microbiome to help prevent and manage human disease.  Since the
Group's inception it has created a wide range of microbiome-based ingredients
and products including prebiotic products like SlimBiome®, WellBiome®,
SweetBiotix® and Microbiome Modulators within its core OptiBiotix Health plc
(OPTI) business, but also skincare through its holdings in SkinBioTherapeutics
PLC (SBTX), and probiotics through ProBiotix Health plc (PBX). These companies
create a diverse portfolio of technologies and products in an emerging area of
healthcare that is of growing interest in consumer markets throughout the
world.

This communication is a "Reach" announcement. Reach is a non-regulatory news
service. By using this service an issuer is confirming that the information
contained in this announcement is of a non-regulatory nature. Information
required to be notified under the AIM Rules for Companies, Market Abuse
Regulation or other regulation would be disseminated as an RNS regulatory
announcement and not on RNS Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAKZGMMRLRGVZM



            Copyright 2019 Regulatory News Service, all rights reserved